hit counter
China Biologic Products Holdings, Inc. (CBPO) Stock News Sentiment & Price - Sentifly
CBPO - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



China Biologic Products Holdings, Inc. (CBPO)

China
Biotechnology
NASDAQ
CBPO Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
CBPO Latest news
PRNewsWire
Neutral
China Biologic Announces Completion of Going Private Transaction
2021-04-20 16:30

BEIJING, April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced the completion of its merger (the "Merger") with CBPO Group Limited ("Merger Sub"), a wholly owned subsidiary of CBPO Holdings Limited ("Parent"), pursuant to the previously announced agreement and plan of merger, dated as of November 19, 2020 (the "Merger Agreement") among the Company, Parent and Merger Sub. As a result of the Merger, the Company became a wholly owned subsidiary of Parent and will cease to be a publicly traded company.

PRNewsWire
Neutral
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
2021-03-29 16:30

BEIJING, March 29, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the fourth quarter and fiscal year of 2020. Fourth Quarter 2020 Financial Highlights Total sales in the fourth quarter of 2020 increased by 9.7% in USD terms and 3.2% in RMB terms to $112.1 million from $102.2 million in the same quarter of 2019.

Seeking Alpha
Neutral
China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q3 2020 Results - Earnings Call Transcript
2020-11-25 21:29

China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q3 2020 Results - Earnings Call Transcript

PRNewsWire
Neutral
China Biologic Products to Report Third Quarter 2020 Financial Results
2020-11-13 08:00

BEIJING, Nov. 13, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its third quarter 2020 financial...

InvestorPlace
Negative
7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio
2020-10-23 14:05

It's a good time to separate the weak from the strong. The post 7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio appeared first on InvestorPlace.

Seeking Alpha
Neutral
China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q2 2020 Results - Earnings Call Transcript
2020-08-18 12:49

China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q2 2020 Results - Earnings Call Transcript

GuruFocus
Positive
5 Health Care Stocks Boosting Earnings
2020-06-30 10:18

The following companies have grown their earnings per share over a five-year period.

Seeking Alpha
Neutral
China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q4 2019 Results - Earnings Call Transcript
2020-03-13 11:07

China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q4 2019 Results - Earnings Call Transcript

InvestorPlace
Positive
7 Ideal Mid-Cap Stocks for a Diverse Portfolio
2019-12-20 07:02

These stocks slot into any portfolio and will pack a special punch.

InvestorPlace
Positive
7 Exciting Biotech Stocks to Buy Now
2019-12-02 14:57

Many of these biotech companies are beating the Nasdaq Biotech Index. With cutting-edge therapies, these are great names to buy.

Loading more news...